Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Earning passive income online is more accessible than ever. Discover effective strategies to start your online income journey.
15,272 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Bitcoin crashed below $60k as selling pressure intensified and on-chain activity signaled coins moving toward exchang...
U.S. Q1 GDP was revised higher to a 2.1% annualized pace, topping prior estimates. The gain sparks relief in markets ...
Idaho's dairy industry, valued at about $20 billion, is grappling with labor shortages driven by tightened immigratio...
When disasters hit, celebrities can rally support in powerful ways. This guide shows you how to give wisely, budget f...
This year brought a sharp retreat in Accenture’s stock. The drop isn’t just a price move—it's a signal. This guide br...
Strategy reveals a potential strategy sell $1.25 billion in Bitcoin to strengthen liquidity and investor confidence a...
ASML and Applied Materials ride an AI-capex wave, but their business models diverge. ASML benefits from EUV pricing p...
Forward Industries jumped after confirming it expanded its SOL holdings by more than 500,000 coins. Here’s what this ...
When headlines shout about dream finders homes struggles, investors should look past the noise and examine the fundam...
A major reinsurance renewal helped Lemonade rewrite its profit picture, sending LMND higher in a short week. Here’s w...
In 2026, Nvidia stock has cooled from its sky-high run. If you own NVDA, you’ll want a clear plan: trim profits, reba...